Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study
Abstract Background Therapy for Type 2 diabetes (T2D) has been transformed by the introduction of newer agents like Glucagon like Peptide Receptor Agonists (GLP-1RA) and Sodium-glucose linked transporter inhibitors (SGLT2i). However with co-initiation of SGLT2i and GLP-1RA in the DURATION 8 trial an...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2018-05-01
|
| シリーズ: | Clinical Diabetes and Endocrinology |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s40842-018-0061-8 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|